APPENDIX
K
SCIENTIFIC
PRIORITY
FOR historical purposes it may be useful
to set down here the places of publication and dates of the writer’s fundamental
discoveries relating to the origin, nature, and scientific (enzyme or
pancreatic) treatment of cancer or malignant disease.
Asexual
(trophoblastic) nature of carcinoma: Lancet, June 21, 1902.
Asexual
(trophoblastic) nature of sarcoma: Lancet, October 29, 1904.
Origin
from a germ-cell : Lancet, June 21, 1902 amended to origin from a
germ-cell embryonic in destiny, Lancet, October 29, 1904.
The
use of “ the secretion of that important digestive gland, the pancreas,” and
including the ferment trypsin, in a public lecture at Liverpool University,
January 20, 1905, and again in the Lancet, February 4, 1905.
Experimental
proof of the destructive action of Fairchild’s trypsin upon the living
cancer-cell : Medical Press, December 20, 1905, and British Medical
Journal, January 20, 1906.
The
place of amylopsin in the enzyme treatment of cancer : Medical Record, New
York, June 23, 1906.
279